Immunization of non-Hodgkin lymphoma patients with a novel recombinant idiotype vaccine: Results from a phase I clinical trial

被引：0
|
作者：
Bertinetti, C [1 ]
Dierbach, H [1 ]
Mauerer, K [1 ]
Mikesch, K [1 ]
Veelken, H [1 ]
机构：
[1] Univ Freiburg, Med Ctr, Dept Hematol Oncol, D-7800 Freiburg, Germany
来源：
EXPERIMENTAL HEMATOLOGY | 2005年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
78
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [21] Active immunization with the idiotype of non-Hodgkin lymphoma elicits an immune response covering idiotype-negative tumor variants.
    Caspar, CB
    Levy, S
    Levy, R
    BLOOD, 1995, 86 (10) : 2134 - 2134
  • [22] Clinical Trial Availability in Adolescent and Young Adult Patients with Non-Hodgkin Lymphoma
    Crawley, Melissa Ann
    Stein, Matthew K.
    Patel, Kruti
    Martin, Michael G.
    BLOOD, 2016, 128 (22)
  • [23] A novel fully human anti-CD20 monoclonal antibody. First clinical results from an ongoing phase I/II trial in patients with follicular non-Hodgkin's lymphoma
    Hagenbeek, A
    Plesner, T
    Walewski, J
    Kneba, M
    Petersen, J
    Radford, J
    ANNALS OF ONCOLOGY, 2005, 16 : 71 - 71
  • [24] TREATMENT RESULTS OF 1110 PATIENTS WITH NON-HODGKIN LYMPHOMA
    Buyukpamukcu, Munevver
    Varan, Ali
    Akyuz, Canan
    Yalcin, Bilgehan
    Kale, Gulsev
    Kesik, Vural
    Kutluk, Tezer
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 758 - 758
  • [25] Final results of a phase I radioimmunotherapy trial using 186Re-epratuzumab for the treatment of patients with non-Hodgkin's lymphoma
    Postema, EJ
    Raemaekers, JMM
    Oyen, WJG
    Boerman, OC
    Mandigers, CMPW
    Goldenberg, DM
    van Dongen, GAMS
    Corstens, FHM
    CLINICAL CANCER RESEARCH, 2003, 9 (10) : 3995S - 4002S
  • [26] Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: Phase I/II clinical trial results
    Leonard, JP
    Coleman, M
    Ketas, JC
    Chadburn, A
    Furman, R
    Schuster, MW
    Feldman, EJ
    Ashe, M
    Schuster, SJ
    Wegener, WA
    Hansen, HJ
    Ziccardi, H
    Eschenberg, M
    Gayko, U
    Fields, SZ
    Cesano, A
    Goldenberg, DM
    CLINICAL CANCER RESEARCH, 2004, 10 (16) : 5327 - 5334
  • [27] A phase 2 trial to evaluate the efficacy of recombinant idiotype vaccine with abbreviated course of granulocyte-macrophage colony-stimulating factor adjuvant in follicular non-Hodgkin's lymphoma.
    Vose, J
    Bierman, P
    Hollingsworth, M
    Ingolia, D
    Denney, D
    Kunkel, L
    BLOOD, 2002, 100 (11) : 361A - 361A
  • [28] Update on interim results in Genta's anticode phase I/II non-Hodgkin's lymphoma trial presented
    不详
    DRUG NEWS & PERSPECTIVES, 1996, 9 (06) : 364 - 365
  • [29] Idiotype Immunization Following High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma
    Holman, Peter R.
    Costello, Caitlin
    deMagalhaes-Silverman, Margarida
    Corringham, Sue
    Castro, Januario
    Ball, Edward D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : 257 - 264
  • [30] Idiotype Immunization Following High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma
    Costello, Caitlin L.
    Holman, Peter
    de Magalhaes-Silverman, Margarida
    Corringham, Sue
    Castro, Januario E.
    Ball, Edward D.
    BLOOD, 2011, 118 (21) : 1724 - 1724
12345